Trial intelligence / Profile preview

Dose recommendations for intravenous colistin in pediatric patients

TCTR20180526001Completed

Sponsor
Principal investigator
Start
May 2018
Modality
Peptides
Countries
1
01

Overview

Single-arm trial of colistin, sponsored by Principal investigator. Primary endpoints: Population pharmacokinetic parameters of colistin and Dose recommendation for pediatric intravenous colistin. Started May 2018; status: completed.

02

Drugs

colistin

Beyond the preview

Go deeper on TCTR20180526001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180526001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call